https://www.prnewswire.com/news-releases/relmada-therapeutics-allowed-patent-application-in-china-covering-nmda-receptor-antagonist-d-methadone-for-treatment-of-psychiatric-symptoms-300694646.html
Relmada Therapeutics Allowed Patent Application in China Covering NMDA Receptor Antagonist...
/PRNewswire/ -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system...
nmda receptor antagonistpatent applicationin chinatherapeuticsallowed
https://pure.johnshopkins.edu/en/publications/selective-nmda-glutamate-receptor-antagonist-effects-on-plasticit/
Selective NMDa Glutamate Receptor Antagonist Effects on Plasticity of Sensory Inputs from...
nmda glutamate receptorselectiveantagonisteffectsplasticity